Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy.

Sticchi C, Alberti M, Artioli S, Assensi M, Baldelli I, Battistini A, Boni S, Cassola G, Castagnola E, Cattaneo M, Cenderello N, Cristina ML, De Mite AM, Fabbri P, Federa F, Giacobbe DR, La Masa D, Lorusso C, Marioni K, Masi VM, Mentore B, Montoro S, Orsi A, Raiteri D, Riente R, Samengo I, Viscoli C, Carloni R; Collaborative Group for the Point Prevalence Survey of healthcare-associated infections in Liguria.

J Hosp Infect. 2017 Dec 15. pii: S0195-6701(17)30679-5. doi: 10.1016/j.jhin.2017.12.008. [Epub ahead of print]

PMID:
29253622
2.

Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study.

Floridia M, Masuelli G, Ravizza M, Tassis B, Cetin I, Sansone M, Degli Antoni A, Simonazzi G, Maccabruni A, Francisci D, Frisina V, Liuzzi G, Dalzero S, Tamburrini E; Italian Group on Surveillance of Antiretroviral Treatment in Pregnancy.

J Antimicrob Chemother. 2017 Dec 13. doi: 10.1093/jac/dkx478. [Epub ahead of print]

PMID:
29244115
3.

Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area.

Cristina ML, Alicino C, Sartini M, Faccio V, Spagnolo AM, Del Bono V, Cassola G, De Mite AM, Crisalli MP, Ottria G, Schinca E, Lo Pinto G, Bottaro LC, Viscoli C, Orsi A, Giacobbe DR, Icardi G; Genoan Klebsiella pneumoniae research group.

J Infect Public Health. 2017 Jun 28. pii: S1876-0341(17)30146-6. doi: 10.1016/j.jiph.2017.06.003. [Epub ahead of print]

4.

Rate, correlates and outcomes of repeat pregnancy in HIV-infected women.

Floridia M, Tamburrini E, Masuelli G, Martinelli P, Spinillo A, Liuzzi G, Vimercati A, Alberico S, Maccabruni A, Pinnetti C, Frisina V, Dalzero S, Ravizza M; Italian Group for Surveillance of Antiretroviral Treatment in Pregnancy.

HIV Med. 2017 Jul;18(6):440-443. doi: 10.1111/hiv.12473. Epub 2016 Dec 21.

PMID:
28000379
5.

Epidemiology and biomolecular characterization of carbapenem-resistant klebsiella pneumoniae in an Italian hospital.

Cristina ML, Sartini M, Ottria G, Schinca E, Cenderello N, Crisalli MP, Fabbri P, Lo Pinto G, Usiglio D, Spagnolo AM.

J Prev Med Hyg. 2016 Sep;57(3):E149-E156. Review.

6.

Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV.

Floridia M, Pirillo MF, Degli Antoni A, Molinari A, Tamburrini E, Pinnetti C, Guaraldi G, Nardini G, Masuelli G, Dalzero S, Cetin I, Sansone M, Amici R, Ravizza M; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

Clin Microbiol Infect. 2016 Sep;22(9):818-820. doi: 10.1016/j.cmi.2016.06.017. Epub 2016 Jul 9. No abstract available.

7.

Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series.

Floridia M, Masuelli G, Meloni A, Cetin I, Tamburrini E, Cavaliere AF, Dalzero S, Sansone M, Alberico S, Guerra B, Spinillo A, Chiadò Fiorio Tin M, Ravizza M; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

BJOG. 2017 Jul;124(8):1218-1223. doi: 10.1111/1471-0528.14183. Epub 2016 Jun 20.

PMID:
27319948
8.

Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013.

Hoxha A, Kärki T, Giambi C, Montano C, Sisto A, Bella A, D'Ancona F; Study Working Group.

J Hosp Infect. 2016 Jan;92(1):61-6. doi: 10.1016/j.jhin.2015.06.018. Epub 2015 Jul 29.

PMID:
26319590
9.

Diagnostic and therapeutic appropriateness in bone and joint infections: results of a national survey.

Esposito S, Russo E, De Simone G, Gioia R, Petta E, Leone S, Noviello S, Artioli S, Ascione T, Bartoloni A, Bassetti M, Bertelli D, Boccia G, Borrè S, Brugnaro P, Caramello P, Coen M, Crisalli MP, De Caro F, Dodi F, Fantoni M, Foti G, Giacometti A, Leoncini F, Libanore M, Migliore S, Venditti M.

J Chemother. 2016 Jun;28(3):191-7. doi: 10.1179/1973947815Y.0000000012.

PMID:
25800800
10.

Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy.

Floridia M, Pinnetti C, Ravizza M, Frisina V, Cetin I, Fiscon M, Sansone M, Antoni AD, Guaraldi G, Vimercati A, Guerra B, Placido G, Dalzero S, Tamburrini E; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

HIV Clin Trials. 2014 May-Jun;15(3):104-15. doi: 10.1310/hct1503-104.

PMID:
24947534
11.

Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study.

Floridia M, Ravizza M, Masuelli G, Giacomet V, Martinelli P, Degli Antoni A, Spinillo A, Fiscon M, Francisci D, Liuzzi G, Pinnetti C, Marconi AM, Tamburrini E; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

J Antimicrob Chemother. 2014 May;69(5):1377-84. doi: 10.1093/jac/dkt497. Epub 2013 Dec 25.

PMID:
24370933
12.

Pregnancy outcomes in HIV-infected women of advanced maternal age.

Liuzzi G, Pinnetti C, Floridia M, Tamburrini E, Masuelli G, Dalzero S, Sansone M, Giacomet V, Degli Antoni AM, Guaraldi G, Meloni A, Maccabruni A, Alberico S, Portelli V, Ravizza M; Italian Group On Surveillance On Antiretroviral Treatment In Pregnancy.

HIV Clin Trials. 2013 May-Jun;14(3):110-9. doi: 10.1310/hct1403-110.

PMID:
23835513
13.

Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.

Floridia M, Mastroiacovo P, Tamburrini E, Tibaldi C, Todros T, Crepaldi A, Sansone M, Fiscon M, Liuzzi G, Guerra B, Vimercati A, Vichi F, Vicini I, Pinnetti C, Marconi AM, Ravizza M; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

BJOG. 2013 Nov;120(12):1466-75. doi: 10.1111/1471-0528.12285. Epub 2013 May 31.

14.

Body mass index and weight gain in pregnant women with HIV: a national study in Italy.

Floridia M, Ravizza M, Masuelli G, Dalzero S, Pinnetti C, Cetin I, Meloni A, Spinillo A, Rubino E, Francisci D, Tamburrini E; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

Clin Infect Dis. 2013 Apr;56(8):1190-3. doi: 10.1093/cid/cis1225. Epub 2013 Jan 8. No abstract available.

PMID:
23300243
15.

Use of specific antiretroviral regimens among HIV-infected women in Italy at time of conception: 2001-2011.

Floridia M, Ravizza M, Guaraldi G, Pinnetti C, Martinelli P, Tamburrini E; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

AIDS Patient Care STDS. 2012 Aug;26(8):439-43. doi: 10.1089/apc.2012.0116. Epub 2012 Jun 4. No abstract available.

PMID:
22663250
16.

Glucose plasma levels and pregnancy outcomes in women with HIV.

Meloni A, Floridia M, Alberico S, Tamburrini E, Pinnetti C, Bucceri A, Masuelli G, Viganò A, Liuzzi G, Antoni AD, Guaraldi G, Spinillo A, Marocco R, Dalzero S, Ravizza M; Italian Group On Surveillance On Antiretroviral Treatment In Pregnancy.

HIV Clin Trials. 2011 Nov-Dec;12(6):299-312. doi: 10.1310/hct1206-299.

PMID:
22189149
17.

Pregnancy outcomes in women with advanced HIV infection in Italy.

Baroncelli S, Tamburrini E, Ravizza M, Pinnetti C, Dalzero S, Scatà M, Crepaldi A, Liuzzi G, Molinari A, Vimercati A, Maccabruni A, Francisci D, Rubino E, Floridia M; Italian Group On Surveillance On Antiretroviral Treatment In Pregnancy.

AIDS Patient Care STDS. 2011 Nov;25(11):639-45. doi: 10.1089/apc.2011.0172. Epub 2011 Sep 23.

18.

Spread of multidrug carbapenem-resistant Acinetobacter baumannii in different wards of an Italian hospital.

Cristina ML, Spagnolo AM, Ottria G, Sartini M, Orlando P, Perdelli F; Galliera Hospital Group.

Am J Infect Control. 2011 Nov;39(9):790-4. doi: 10.1016/j.ajic.2011.01.016. Epub 2011 Jun 25.

PMID:
21704428
19.

Rubella susceptibility profile in pregnant women with HIV.

Floridia M, Pinnetti C, Ravizza M, Tibaldi C, Sansone M, Fiscon M, Guaraldi G, Guerra B, Alberico S, Spinillo A, Castelli P, Dalzero S, Cavaliere AF, Tamburrini E; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

Clin Infect Dis. 2011 Apr 1;52(7):960-2. doi: 10.1093/cid/cir040. No abstract available.

PMID:
21427406
20.

Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy.

Floridia M, Ravizza M, Pinnetti C, Tibaldi C, Bucceri A, Anzidei G, Fiscon M, Molinari A, Martinelli P, Dalzero S, Tamburrini E; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

HIV Clin Trials. 2010 Nov-Dec;11(6):303-11. doi: 10.1310/hct1106-303.

PMID:
21239358

Supplemental Content

Loading ...
Support Center